Access Pharmaceuticals, Inc. (ACCP) Expands Reach with CSPN
Access Pharmaceuticals, Inc. yesterday announced that Community Specialty Pharmacy Network has joined its specialty pharmacy network for the MuGard product. MuGard is a new product being produced by Access for oral mucositis. Houston, Texas-based Access Pharmaceuticals is a biopharmaceutical that focuses on developing and marketing a series of proprietary products for the care of cancer patients. The company's product line includes MuGard, ProLindac (for treating ovarian cancer) and Thirabine (a new nucleoside). Access also produces the CobaCyte and CobOral drug delivery systems. CSPN has more than 180 member pharmacies and offers a range of services, including mail distribution, therapy management,…